conflict of interest

My Response To Dr. Pies

November 17, 2015

In the October 2015 issue of the Behavior Therapist (pages 206-213), Jeffrey Lacasse, PhD, and Jonathan Leo, PhD, published an article titled Antidepressants and the Chemical Imbalance Theory of Depression: A Reflection and Update on the Discourse, I thought the article had particular merit, and I drew attention to it in a post dated November […]

Read the rest →

Allen Frances ‘Replies’

June 24, 2015

BACKGROUND On June 19, 2015, I published a post titled Allen Frances’ Ties to Johnson & Johnson.  In that post, I set out some very serious allegations against Dr. Frances.  I drew these allegations from a document titled Special Witness Report dated October 15, 2010.  The report was written by David Rothman, PhD, Professor of […]

Read the rest →

Allen Frances’ Ties to Johnson & Johnson

June 19, 2015

INTRODUCTION I recently came across an article titled Diagnosisgate: Conflict of Interest at the Top of the Psychiatric Apparatus, by Paula Caplan, PhD.  The article was published in Aporia, the University of Ottawa nursing journal, in January 2015.  Aporia is “a peer-reviewed, bilingual, and open access journal dedicated to scholarly debates in nursing and the […]

Read the rest →

Neuroleptic Drugs And Mortality

June 1, 2015

In November of last year, the Schizophrenia Bulletin published online a research study:  Antipsychotic Treatment and Mortality in Schizophrenia, by Minna Torniainen et al.  The research was conducted in Sweden. The authors offer the following background for the study: “It is generally believed that long-term use of antipsychotics increases mortality and, especially, the risk of […]

Read the rest →

Antidepressant Drugs and Suicide Rates

March 2, 2015

In 2010, Acta Psychiatrica Scandinavica published a study by Göran Isacsson et al.  The paper was titled Antidepressant medication prevents suicide in depression.  Here’s the conclusion: “The finding that in-patient care for depression did not increase the probability of the detection of antidepressants in suicides is difficult to explain other than by the assumption that […]

Read the rest →

Pharma-funded Research

September 26, 2014

On August 20, 2014, Psychiatry Advisor published an article on its website.  The article was written by Leslie Citrome, MD, a professor of psychiatry at New York Medical College in Valhalla, NY, and a member of the Board of Directors of the American Society of Clinical Psychopharmacology.  The article is called Is Bias Against Pharma-Funded […]

Read the rest →

From Hell to Hope

June 12, 2014

  Can.you tell I have a cat just by looking at me?  Can you tell I have a mental illness just by looking at me?I began to change in my early teens, be it hormones and my shifting brain chemistry, or the stress of my parents seperating. Something stressor from the outside flipped on the switch to […]

Read the rest →

The FDA:  The Fox Guards the Hen House

May 7, 2014

In their Fall 2013 issue, the Journal of Law, Medicine, and Ethics published a symposium of papers by members of the Harvard’s Edmond J. Safra Center for Ethics.  The symposium was called Institutional Corruption and Pharmaceutical Policy. The symposium focuses on pharmaceutical products generally, but all the material is relevant and important in the context […]

Read the rest →

Sluggish Cognitive Tempo – A New Diagnosis?

April 29, 2014

On April 11, 2014, journalist Alan Schwarz (brief bio here) published an article in the New York Times on this topic, titled Idea of New attention Disorder Spurs Research, and Debate.  Alan has written extensively on the rising rates of the condition known as ADHD, and on the abuse of the drugs that are used […]

Read the rest →

‘ADHD’ and Dangerous Driving

April 22, 2014

In 2006, Laurence Jerome, a Canadian psychiatrist, and two colleagues wrote a paper titled What We Know About ADHD and Driving Risk: A Literature Review, Meta-Analysis and Critique.  It was published in the Journal of the Canadian Academy of Child and Adolescent Psychiatry in August, 2006. The primary result of the meta-analysis was: “Current data […]

Read the rest →

Investigation of Dan Markingson’s Death

April 11, 2014

I have written on Dan Markingson’s death in an earlier post, and I encourage readers who are not familiar with the case to have a look. It is generally accepted by those of us on this side of the debate that psychiatry does more harm than good, and is organizationally and individually responsible for a […]

Read the rest →

Justina Pelletier and Boston Children’s Hospital

March 6, 2014

Justina Pelletier is the 15-year-old girl who is at the center of a dispute between her parents and the Psychiatry Department at Boston Children’s Hospital. Justina, who lived with her parents in Connecticut, had been diagnosed with mitochondrial disease, a rare and debilitating illness, and had been receiving treatment for this from Mark Korson, MD, […]

Read the rest →

A Blood Test for Schizophrenia with 83% Accuracy?

March 4, 2014

INTRODUCTION An NBC online News article dated October 15, 2010, carried the noteworthy title New blood test may help detect schizophrenia.  Thanks to Francesca for the link. The article was written by Natasha Allen, a freelance medical journalist.  The gist of the article is that there is a new blood test called VeriPsych which “researchers […]

Read the rest →

DSM-5: Dimensionality: Conflicts of Interest

January 25, 2014

In DSM-5 – Dimensional Diagnoses – More Conflicts of Interest? which I posted on December 23, 2013, I drew attention to the fact that David Kupfer, MD, in his position as head of the DSM-5 Task Force, was vigorously promoting a dimensional model of assessment while at the same time was positioning himself to benefit […]

Read the rest →

Training Of Psychiatrists: What The Future Holds

January 20, 2014

Joel Yager, MD, is a Professor of Psychiatry, University of Colorado at Denver School of Medicine.  He started his career as a US Army psychiatrist in 1969, and has held a wide range of clinical and teaching positions in the intervening years.  He has received numerous awards, including lifetime achievement awards from the National Eating […]

Read the rest →

Psychiatry’s Over Reliance On Pharma

January 3, 2014

I recently read The NIMH-CATIE Schizophrenia Study: What Did We Learn? by Jeffrey Lieberman, MD, and T. Scott Stroup, MD, MPH.  The article was published in the American Journal of Psychiatry 168:8, August 2011.   Here are two quotes: “When the CATIE study was designed in 1999-2000, the prevailing opinion of researchers and clinicians alike was […]

Read the rest →

Dr. Lieberman Thanks Dr. Scully

December 28, 2013

As my regular readers know, I am a big fan of Jeffrey Lieberman, MD, eminent President of the American Psychiatric Association.  I study his bulletins on Psychiatric News avidly, not only for the insights they provide in the areas of human frailty and self-deception, but also for their literary qualities of obfuscation and semantic distortion. […]

Read the rest →

DSM-5 – Dimensional Diagnoses – More Conflicts of Interest?

December 23, 2013

BACKGROUND On November 20, JAMA Psychiatry (formerly Archives of General Psychiatry) published an interesting letter.  It was headed: Failure to Report Financial Disclosure Information,  and was signed by Robert D. Gibbons PhD, David J Weiss PhD, Paul A. Pilkonis PhD, Ellen Frank, PhD , and David J. Kupfer MD. The letter is an apology for […]

Read the rest →

CAFÉ Study: Real Science or Marketing Exercise?

December 18, 2013

BACKGROUND On December 8,  I received the following question from a reader:  (The subject matter is the controversial CAFÉ – Comparisons of Atypicals in First Episode of Psychosis – study.  This was the study in which Dan Markingson committed suicide.) “It appears that there was no head-to-head with a control group taking a placebo pill. […]

Read the rest →

Neuroleptics for Children: Harvard’s Shame

December 4, 2013

In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry.  The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics.  The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing […]

Read the rest →

Causes of High Mortality in People Labeled ‘Mentally Ill’

November 12, 2013

ANOTHER VIDEO FROM DR. LIEBERMAN On October 28, Jeffrey Lieberman, MD, President of the APA, made another video.  This one is titled An Important Look at Mortality in Mental Illness: A Decade of Data on Psychotropic Drugs, and was made for Medscape.  You can see the transcript at the same site.  Medscape is a web […]

Read the rest →

The Dangers of SSRI’s

November 7, 2013

SSRI’S AND SUICIDE Bob Fiddaman has a post up today called MHRA Consultant Calls for Antidepressant Use in Young.  The article highlights some of the dangers associated with SSRI’s, and also describes some of the attempts to suppress or discount the significance of this information. Apparently in 2010, Swedish psychiatrist Göran Isacsson, MD, PhD, published […]

Read the rest →

The New Holy Grail: Dysfunctional Neural Circuits

October 22, 2013

There’s a new article on Psychiatric News titled Change, Challenge, and Opportunity: Psychiatry Through the Looking Glass of Research.  It’s dated October 17, and was authored  by Steven Hyman, MD, and Jeffrey Lieberman, MD.  Thanks to Mental Health Law on Twitter for the link. Dr. Lieberman is President of the APA.  Dr. Hyman was Director […]

Read the rest →

The Tide Has Turned

September 28, 2013

Those of us on this side of the psychiatric debate have long maintained that there is a link between the so-called antidepressant drugs and the mass murders that have become an increasingly common feature of American society in recent decades. The call for a formal investigation of this link, however, has been consistently resisted, and […]

Read the rest →

The Link Between Psychiatric Drugs and Violence

September 7, 2013

Thanks to a tweet from Ginger Breggin for the link to a new article on AbleChild.org.  The article is called CT AAG Nervous About Releasing Adam Lanza’s Medical Records:  Disclosure “Can Cause A Lot of People to Stop Taking Their Medications.“  The AbleChild contact person is Sheila Matthews. AbleChild is a national parent rights organization […]

Read the rest →

The Ethics of Disclosing Financial Relationships

August 30, 2013

Recently, Carl Elliott posted a link to a statement written by Jonathan Moreno, PhD, a renowned bioethicist at the University of Pennsylvania. Dr. Moreno’s statement was in reference to an Oregon court case.  The Oregon Department of Justice had accused two cardiologists of concealing information from patients.  Apparently the cardiologists had put heart implants into […]

Read the rest →

Never Mind The Facts; Just Sell More Pills

August 23, 2013

There’s an interesting article, recently published in Journal of Contemporary Psychotherapy, on Springer Link.  It’s titled Shooting the Messenger: The Case of ADHD,  and it was written by Gretchen LeFever Watson, PhD, et al. Apparently some of the authors had noted in 1995 a marked increase in the “diagnosis” and “treatment” of the condition known […]

Read the rest →

Dr. Lieberman is Back

August 6, 2013

Courtesy of Carl Elliott via Twitter, I’ve recently read Dr. Lieberman’s latest post on Psychiatric News. It’s called – believe it or not – Time to Re-Engage With Pharma? dated August 1, 2013.  And it’s classic Dr. Lieberman sleight of hand. His opening statement, for instance, reads: “Drug companies aren’t held in high esteem by […]

Read the rest →

Are The Second Generation Neuroleptics Good For the Brain?

August 5, 2013

There’s an editorial by Henry Nasrallah, MD, in last month’s edition of Current Psychiatry.  Dr. Nasrallah is the journal’s editor-in-chief.  The title of the article is Haloperidol clearly is neurotoxic.  Should it be banned?  Haloperidol is marketed under the brand name Haldol, but its patent has long expired, and a generic version is available and inexpensive. […]

Read the rest →

The CAFE Study: Dr. Lieberman’s High Moral Ground

July 16, 2013

BACKGROUND The CAFE Study, conducted by Jeffrey Lieberman, MD, et al between 2002 and 2005, has been the subject of much comment.  Carl Elliott, in particular, has written extensively on the matter, including his article The Deadly Corruption of Clinical Trials in Mother Jones. In order to address the issues involved in the CAFE study, we […]

Read the rest →

Psychiatry Is Intrinsically Flawed and Rotten

July 15, 2013

On Twitter yesterday, Robert Stamatakis commented: “I have to ask, I don’t understand.  Do you work in the UK?  Your descriptions of psychiatry are nothing I recognize.  These descriptions of psychiatry are nothing like the practice I see on a daily basis.” I am certainly a very outspoken critic of psychiatry, and in that regard […]

Read the rest →

Pharma Payments to Psychiatrists

May 31, 2013

On March 12 of this year, the Los Angeles Daily News ran an article by Susan Abram titled:  Doctors report big pharma payouts for drug endorsements.  It discusses the financial ties between physicians and drug companies in California. Here are some quotes: “In fact, hundreds of physicians, psychiatrists, and medical school faculty members across California […]

Read the rest →

Pharma Dollars Behind Mental Health Websites

May 25, 2013

There’s an interesting article on MINNPOST, Many mental-illness websites show drug-company bias, study finds, dated May 16.  The article is by Susan Perry, and presents the results of a Web survey of mental health websites conducted by John Read and A. Cain from the University of Auckland, New Zealand.  The original study was published in […]

Read the rest →

The Empire Still Fighting Back: Dr. Lieberman

May 22, 2013

Jeffrey Lieberman, MD, is president-elect of the APA, and is scheduled to take over the reins from Dr. Dilip Jeste this month.  Never in its history has the APA been subject to such scrutiny or criticism from such diverse sources, and one might reasonably have expected Dr. Lieberman to open on a conciliatory note, promising […]

Read the rest →

Bereavement: An “Opportunity” for Psychiatry

May 1, 2013

There’s a new post on Mick Bramham’s website called “A time to grieve, a time to console, and a time to profit?”  You can see it here. You might have thought that, given the adverse publicity that pharma has been receiving in recent years, they would be easing up on their expansionist agenda. But you […]

Read the rest →

Postpartum Depression Not an Illness

April 24, 2013

BACKGROUND The primary purpose of the bio-psychiatric-pharma faction is to expand turf and sell more drugs.  This is a multi-faceted endeavor, one component of which is disease mongering.  This consists of using marketing techniques to persuade large numbers of people that they have an illness which needs to be treated with drugs. With regards to […]

Read the rest →

Psychiatry is a Lost Cause

April 20, 2013

It is easy to vilify psychiatrists.  Their spurious conceptual framework, toxic “treatments’ and blatantly corrupt links to pharma make them easy targets.  Their destructive activities, to which they resolutely cling, invite criticism which they steadfastly ignore.  Any thoughts that perhaps they had seen the errors of their ways have been dashed by the soon-to-be published […]

Read the rest →

More Conflicts of Interest in Psychiatry

April 2, 2013

I’ve come across an article by Lisa Cosgrove et al entitled Conflicts of interest and the quality of recommendations in clinical guidelines.  It was published in the Journal of Evaluation in Clinical Practice in December of last year. As everyone knows, the APA publishes the DSM, but they also publish “Clinical Practice Guidelines” for various “diagnoses,” […]

Read the rest →

The International DSM-5 Response Committee

March 25, 2013

BACKGROUND I recently wrote a post called DSM-5: Another Step in the Wrong Direction.  In that article I argued that DSM-5 was simply another step in the APA’s ongoing agenda to medicalize all human problems and to legitimize the administration of drugs as the front line “solution” to these problems. I also expressed concern that […]

Read the rest →

Pharma’s Subtle but Pernicious Marketing

March 23, 2013

Alice Keys, MD, has recently written a short article for Mad in America.  You can see it here. Dr. Keys points out that to maintain a medical license, one must accumulate continuing education credits, and that these credits have to be approved by state licensing boards. It’s widely known that pharmaceutical companies have largely hijacked […]

Read the rest →